The French Pulmonary Hypertension Registry also assessed a simplified risk scheme composed of three noninvasive variables (FC I–II, 6MWD >440 m and NTproBNP <300 ng·mL−1) and found that this simplified scheme also clearly discriminated mortality risk groups among subjects at follow-up [17]. This evidence concerns the gene NPPB and pulmonary hypertension.